Recombinant expression of TLR5 proteins by ligand supplementation and a leucine-rich repeat hybrid technique

Biochemical and Biophysical Research Communications

Volumn 427, Issue 1, 2012, Pages 119-124

  Hong, Minsun ^a   Yoon, Sung il ^a,b   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Kangwon National University   (South Korea)

Author keywords

Flagellin; Innate immunity; Leucine rich repeat; LRR hybrid; Toll like receptor 5; Variable lymphocyte receptor

Indexed keywords

FLAGELLIN; LEUCINE; LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 5;

ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CARBOXY TERMINAL SEQUENCE; MOLECULAR HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; FLAGELLIN; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECOMBINANT FUSION PROTEINS; TOLL-LIKE RECEPTOR 5;

BACTERIA (MICROORGANISMS); DANIO RERIO; HAGFISH; VERTEBRATA;

EID: 84867647687     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.021     Document Type: Article

References (18)

1. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 2003, 21:335-376.
2. Botos I., Segal D.M., Davies D.R. The structural biology of Toll-like receptors. Structure 2011, 19:447-459.
3. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
4. Yoon S.I., Kurnasov O., Natarajan V., Hong M., Gudkov A.V., Osterman A.L., Wilson I.A. Structural basis of TLR5-flagellin recognition and signaling. Science 2012, 335:859-864.
5. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., Strom E., Gleiberman A.S., Gupta D., Kurnasov O.V., Fort F.L., Osterman A.L., Didonato J.A., Feinstein E., Gudkov A.V. An agonist of Toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008, 320:226-230.
6. Turley C.B., Rupp R.E., Johnson C., Taylor D.N., Wolfson J., Tussey L., Kavita U., Stanberry L., Shaw A. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 2011, 29:5145-5152.
7. Jin M.S., Kim S.E., Heo J.Y., Lee M.E., Kim H.M., Paik S.G., Lee H., Lee J.O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130:1071-1082.
8. Kang J.Y., Nan X., Jin M.S., Youn S.J., Ryu Y.H., Mah S., Han S.H., Lee H., Paik S.G., Lee J.O. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009, 31:873-884.
9. Kim H.M., Park B.S., Kim J.I., Kim S.E., Lee J., Oh S.C., Enkhbayar P., Matsushima N., Lee H., Yoo O.J., Lee J.O. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007, 130:906-917.
10. Yoon S.I., Hong M., Wilson I.A. An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. Nat. Struct. Mol. Biol. 2011, 18:1028-1035.
11. Yoon S.I., Hong M., Han G.W., Wilson I.A. Crystal structure of soluble MD-1 and its interaction with lipid IVa. Proc. Natl. Acad. Sci. USA 2010, 107:10990-10995.
12. Ainge G.D., Martin W.J., Compton B.J., Hayman C.M., Larsen D.S., Yoon S.I., Wilson I.A., Harper J.L., Painter G.F. Synthesis and Toll-like receptor 4 (TLR4) activity of phosphatidylinositol dimannoside analogues. J. Med. Chem. 2011, 54:7268-7279.
13. Jin M.S., Lee J.O. Application of hybrid LRR technique to protein crystallization. BMB Rep. 2008, 41:353-357.
14. Kim H.M., Oh S.C., Lim K.J., Kasamatsu J., Heo J.Y., Park B.S., Lee H., Yoo O.J., Kasahara M., Lee J.O. Structural diversity of the hagfish variable lymphocyte receptors. J. Biol. Chem. 2007, 282:6726-6732.
15. Andersen-Nissen E., Smith K.D., Bonneau R., Strong R.K., Aderem A. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin. J. Exp. Med. 2007, 204:393-403.
16. Hozjan V., Guo K., Wu X., Oppermann U. Ligand supplementation as a method to increase soluble heterologous protein production. Expert Rev. Proteomics 2008, 5:137-143.
17. Li C., Schwabe J.W., Banayo E., Evans R.M. Coexpression of nuclear receptor partners increases their solubility and biological activities. Proc. Natl. Acad. Sci. USA 1997, 94:2278-2283.
18. Stumpp M.T., Forrer P., Binz H.K., Pluckthun A. Designing repeat proteins: modular leucine-rich repeat protein libraries based on the mammalian ribonuclease inhibitor family. J. Mol. Biol. 2003, 332:471-487.